Morgan Stanley
EDVA

Morgan Stanley’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Morgan Stanley’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-949
Closed -$8.96K – 8422
2025
Q3 		$8.96K Hold
949
– – ﹤0.01% 6933
2025
Q2 		$14.3K Hold
949
– – ﹤0.01% 6762
2025
Q1 		$5.31K Buy
+949
New +$26.6K ﹤0.01% 6972
2024
Q4 		– Sell
-6
Closed -$252 – 8072
2024
Q3 		$252 Hold
6
– – ﹤0.01% 7368
2024
Q2 		$230 Sell
6
-38
-86% -$1.78K ﹤0.01% 7289
2024
Q1 		$3.22K Sell
44
-25
-36% -$1.99K ﹤0.01% 6991
2023
Q4 		$6.08K Sell
69
-20
-22% -$1.9K ﹤0.01% 6789
2023
Q3 		$8.38K Hold
89
– – ﹤0.01% 6791
2023
Q2 		$15.9K Hold
89
– – ﹤0.01% 6638
2023
Q1 		$23.3K Sell
89
-16
-15% -$3.17K ﹤0.01% 6569
2022
Q4 		$16.2K Buy
105
+29
+38% +$5.09K ﹤0.01% 6761
2022
Q3 		$17K Buy
76
+18
+31% +$6.83K ﹤0.01% 6863
2022
Q2 		$28K Hold
58
– – ﹤0.01% 6858
2022
Q1 		$26K Sell
58
-18
-24% -$9.18K ﹤0.01% 7026
2021
Q4 		$14K Buy
76
+56
+280% +$15.1K ﹤0.01% 7348
2021
Q3 		$6K Buy
20
+9
+82% +$4.07K ﹤0.01% 7455
2021
Q2 		$6K Buy
+11
New +$6.02K ﹤0.01% 7352

Other funds holding EDVA

LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley's EDVA Position: Q4 2025 in Review

Morgan Stanley sold out of Endovia Health Sciences, Inc. (EDVA) in Q4 2025, closing a stake of 949 shares — an estimated $8.96K sold.

Morgan Stanley first reported a position in EDVA in Q2 2021 and held it in 17 quarters. The position peaked at $28K in Q2 2022. 13 funds tracked by Wall St. Rank hold EDVA as of Q4 2025.

  • Morgan Stanley reported no remaining Endovia Health Sciences, Inc. position as of Q4 2025 after selling out during the quarter.
  • Morgan Stanley sold 949 Endovia Health Sciences, Inc. shares in Q4 2025, an estimated $8.96K.
  • Morgan Stanley first reported a position in Endovia Health Sciences, Inc. in Q2 2021 and held it in 17 quarters.
  • Morgan Stanley's Endovia Health Sciences, Inc. position peaked at $28K in Q2 2022.
  • 13 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.